NexTech’s InfernoAR Lands Annual Contract With Real Asset Media as its Video Conference Virtual Events Platform
NEW YORK and TORONTO, June 22, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), […]
Molecular Templates’ Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2020 Highlight Evolution of ETB Platform
Update Provided Phase I Study of MT-5111 in HER2-positive CancersConference Call and Webcast to Discuss AACR Posters on June 25th […]
Kelly® Announces Specialty Portfolio Presidents, Appoints Chief Administrative Officer
TROY, Mich., June 22, 2020 (GLOBE NEWSWIRE) — Kelly, a global leader in providing workforce solutions, today announced the appointment […]
TSX News -
New Data Show Theratechnologies’ SORT1+ Technology is Effective in Many Treatment-Resistant Cancers
Peptide-drug conjugates TH1902 and TH1904 show significant reduction in the formation of vasculogenic mimicry by targeting the sortilin receptorCurcumin shows […]
TSX News -
Helix BioPharma Corp. to Present at Proactive One2One Virtual Investor Forum
RICHMOND HILL, Ontario, June 22, 2020 (GLOBE NEWSWIRE) — Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology […]
HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB‑101
Interim data demonstrate that HB‑101 is well toleratedHB-101 elicits T cell and B cell responses in the target populationNEW YORK […]
Zscaler Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes Due 2025
SAN JOSE, Calif., June 22, 2020 (GLOBE NEWSWIRE) — Zscaler, Inc. (Nasdaq: ZS) today announced that it intends to offer $1.0 […]
Autolus Therapeutics presents new preclinical data during the Virtual 2020 AACR Annual Meeting
– AUTO5 in T cell lymphoma – new in vitro and in vivo data presented demonstrating highly selective targeting of […]
Chimerix Appoints Allen Melemed, M.D. as Chief Medical Officer
DURHAM, N.C., June 22, 2020 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to […]
Altimmune Announces IND Clearance for a Phase 2 Trial of HepTcell™ Immunotherapeutic for the Treatment of Chronic Hepatitis B
GAITHERSBURG, Md., June 22, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the […]
